Compare TSLX & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TSLX | INSP |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2011 | 2018 |
| Metric | TSLX | INSP |
|---|---|---|
| Price | $17.78 | $41.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 16 |
| Target Price | $21.61 | ★ $94.00 |
| AVG Volume (30 Days) | 765.5K | ★ 1.1M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 10.82% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | N/A | $8.02 |
| Revenue Next Year | $1.20 | $8.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $16.99 | $39.61 |
| 52 Week High | $25.17 | $151.41 |
| Indicator | TSLX | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 32.91 |
| Support Level | $17.25 | N/A |
| Resistance Level | $18.65 | $59.40 |
| Average True Range (ATR) | 0.52 | 2.84 |
| MACD | -0.13 | -0.86 |
| Stochastic Oscillator | 20.31 | 12.43 |
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.